Long-Term Follow-up Study of ADVM-043

Clinical trial NCT03804021 · COMPLETED

Trial details

NCT number: NCT03804021
Sponsor: Adverum Biotechnologies, Inc.
Status: COMPLETED
Study type: OBSERVATIONAL

Alpha-1 Antitrypsin Deficiency

Start date: 2018-12-27
Primary completion: 2021-12-06
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.